BamSEC and AlphaSense Join Forces
Learn More

Arrowhead Pharmaceuticals Inc.

NASDAQ: ARWR    
Share price (12/20/24): $19.45    
Market cap (12/20/24): $2.420 billion

Material Contracts Filter

EX-10.49
from 10-K 48 pages Material contract
12/34/56
EX-10.48
from 10-K 70 pages Material contract
12/34/56
EX-10.1
from 10-Q 10 pages Material contract
12/34/56
EX-10.1
from 10-Q 97 pages Material contract
12/34/56
EX-10.39
from 10-K 4 pages Material contract
12/34/56
EX-10.11
from 10-K 7 pages Material contract
12/34/56
EX-10.9
from 10-K 5 pages Material contract
12/34/56
EX-10.7
from 10-K 5 pages Material contract
12/34/56
EX-10.1
from 10-Q 43 pages Royalty Purchase Agreement by and Between Arrowhead Pharmaceuticals, Inc. and Royalty Pharma Investments 2019 Icav Dated as of November 9, 2022
12/34/56
EX-10.1
from 10-Q 7 pages Recitals Agreement
12/34/56
EX-10.6
from 10-Q 12 pages Separation and Release of Claims Agreement
12/34/56
EX-10.2
from 10-Q 50 pages Lease Agreement
12/34/56
EX-10.1
from 10-Q 106 pages Exclusive License Agreement by and Between Arrowhead Pharmaceuticals, Inc. and Glaxosmithkline Intellectual Property (No. 3) Limited Dated as of 22 November 2021
12/34/56
EX-10.4
from 10-Q 58 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Collaboration and License Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Stock Option Grant 2021 Incentive Plan Notice of Grant
12/34/56
EX-10.1
from 10-Q 5 pages Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan Performance Restricted Stock Unit Agreement
12/34/56
EX-10.4
from 10-Q 5 pages Seventh Amendment to Lease Agreement
12/34/56
EX-10.3
from 10-Q 6 pages Sixth Amendment to Lease Agreement
12/34/56
EX-10.2
from 10-Q 11 pages First Amendment to Office Lease
12/34/56